Volver a Ensayos Clínicos
NCT07782164
Efficacy of Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Traducción pendiente · disponible pronto
Reclutando
Descripción
The goal of this single-center observational cohort study, based on a registry combining retrospectively and prospectively collected data, is to investigate the short- and long-term effects of irreversible electroporation (IRE) in men and women over the age of 18 who receive IRE for recurrence of pelvic tumors not suitable for other local treatment options such as surgery, thermal ablation, and radiotherapy. The main question it aims to answer is whether IRE is safe in this population, and secondarily, whether it is effective in controlling local tumor recurrence.
Evidencia de la diana molecular en cáncer colorrectal
Estos fármacos NO son el fármaco de este ensayo. Es la eficacia publicada de OTROS fármacos que atacan la misma diana molecular, mostrada como contexto — no se refiere a este ensayo concreto ni confirma elegibilidad. Revísalo siempre con tu oncólogo.
Aún no hay evidencia documentada en nuestra base para la diana o el fármaco de este ensayo. Esta sección crece a medida que se procesan nuevas publicaciones.
Criterios de Elegibilidad
Inclusion Criteria:
- Measurable disease described on pre-treatment imaging (CT/MRI/PET-CT) (max 6 weeks prior);
- IRE of a recurrent pelvic tumor;
- Unsuitable for other local therapies (surgery/stereotactic body radiation therapy) as described during the multidisciplinary tumor board;
Exclusion Criteria:
- If the treated tumor was biopsied directly prior to MWA and pathology proves the lesion to represent a benign entity;
- Inadequate or insufficient data registered;
- Inadequate or insufficient follow-up;
Información del Ensayo
NCT07782164
Reclutando
Sin fase definida
27 participantes
Abr 2025
Ubicaciones1
Netherlands (1)
Amsterdam UMC
Amsterdam